Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.35
0.0551.67%
Last update: Jul 13, 2:54 PM
Fortress Biotech Inc Analyst Ratings
FBIONASDAQ
Fortress Biotech Analyst Ratings and Price Targets | NASDAQ:FBIO | Benzinga
Fortress Biotech Inc has a consensus price target of $13.25 based on the ratings of 5 analysts. The high is $17 issued by HC Wainwright & Co. on February 23, 2026. The low is $5 issued by Alliance Global Partners on March 19, 2024. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Roth MKM on February 23, 2026, August 21, 2025, and March 11, 2025, respectively. With an average price target of $16.67 between HC Wainwright & Co., HC Wainwright & Co., and Roth MKM, there's an implied 396.77% upside for Fortress Biotech Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Roth MKM
Alliance Global Partners
Roth MKM
1calculated from analyst ratings
Analyst Ratings for Fortress Biotech
Loading calendar...
FAQ
What is the target price for Fortress Biotech (FBIO) stock?
The latest price target for Fortress Biotech (NASDAQ:FBIO) was reported by HC Wainwright & Co. on February 23, 2026. The analyst firm set a price target for $17.00 expecting FBIO to rise to within 12 months (a possible 406.71% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Fortress Biotech (FBIO)?
The latest analyst rating for Fortress Biotech (NASDAQ:FBIO) was provided by HC Wainwright & Co., and Fortress Biotech reiterated their buy rating.
When was the last upgrade for Fortress Biotech (FBIO)?
There is no last upgrade for Fortress Biotech
When was the last downgrade for Fortress Biotech (FBIO)?
There is no last downgrade for Fortress Biotech.
When is the next analyst rating going to be posted or updated for Fortress Biotech (FBIO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fortress Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fortress Biotech was filed on February 23, 2026 so you should expect the next rating to be made available sometime around February 23, 2027.
Is the Analyst Rating Fortress Biotech (FBIO) correct?
While ratings are subjective and will change, the latest Fortress Biotech (FBIO) rating was a reiterated with a price target of $17.00 to $17.00. The current price Fortress Biotech (FBIO) is trading at is $3.36, which is out of the analyst’s predicted range.
